Fennec Pharmaceuticals (FENC) Shares Outstanding (Weighted Average) (2010 - 2025)

Fennec Pharmaceuticals (FENC) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $28.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 4.7% year-over-year to $28.6 million; the trailing twelve-month figure through Dec 2025 stood at $28.6 million (up 4.7% YoY), and the FY2025 full-year result was $28.6 million, up 4.7% from the prior year.
• Shares Outstanding (Weighted Average) for Q4 2025 stood at $28.6 million, up from $27.7 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $28.6 million in Q4 2025 and bottomed at $39000.0 in Q4 2021.
• The 5-year median for Shares Outstanding (Weighted Average) is $26.3 million (2022), against an average of $21.5 million.
• The widest annual swing landed in 2021, when Shares Outstanding (Weighted Average) soared 66574.36%; it then plunged 99.45% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $39000.0 in 2021, then soared by 284.62% to $150000.0 in 2022, then changed by 0.0% to $150000.0 in 2023, then soared by 18096.0% to $27.3 million in 2024, then climbed by 4.7% to $28.6 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $28.6 million (Q4 2025), $27.7 million (Q3 2025), and $150000.0 (Q2 2025), per Business Quant data.

Peer Comparison